Résumé :
|
Many patients and families around the world are aware that clinical trials in neuromuscular diseases are now running and seek information on whether they can get involved. TREAT-NMD regularly receives questions from patients and families anxious to find out which trials are happening, which clinics are involved, and which patients might be eligible. We have therefore put these questions to the pharmaceutical companies running the trials, and will publish their responses on the TREAT-NMD website. We hope that this will help to clarify some of the questions patients and families have about clinical trials. The first set of questions was sent to GSK, who have a program in Duchenne muscular dystrophy, and we have now published their responses online. In the future we will be asking similar questions of the other companies involved in trials for DMD and other neuromuscular diseases. (TREAT-NMD Newsletter, 25th February 2011)
|